🇺🇸 Belviq in United States

2,729 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 524 reports (19.2%)
  2. Headache — 515 reports (18.87%)
  3. Fatigue — 457 reports (16.75%)
  4. Dizziness — 364 reports (13.34%)
  5. Nausea — 225 reports (8.24%)
  6. Weight Increased — 198 reports (7.26%)
  7. Somnolence — 133 reports (4.87%)
  8. Drug Effect Decreased — 114 reports (4.18%)
  9. Feeling Abnormal — 108 reports (3.96%)
  10. Constipation — 91 reports (3.33%)

Source database →

Other Metabolic approved in United States

Frequently asked questions

Is Belviq approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Belviq in United States?

Columbia University is the originator. The local marketing authorisation holder may differ — check the official source linked above.